Gilda Witte

Chief Executive of Ovarian Cancer Action

Menu

Skip to content
  • Home
  • About
  • Useful Links

Genetics and ovarian cancer

Advances in genetic testing and knowledge enabling the identification of the ‘faulty’ BRCA1/2 gene mean that women with a family Continue reading →

AAC

I think it must be the season for conferences: In September I went to the American Association for Cancer Research’s Continue reading →

Call for new grant applications

We have had a grant call out for the last few months and we have been receiving lots of new Continue reading →

Much to celebrate

Yesterday was a truly remarkable day for Ovarian Cancer Action. We (along with Imperial College, London) held a Symposium at Continue reading →

US Supreme Court decides human DNA cannot be patented

The BBC headline: “US Supreme Court decides that human DNA cannot be patented”, neatly sums up today’s report on the Continue reading →

Apply for one of our grants…

31st May 2013 Today we are issuing a call for new research grant applications. This is a big deal and Continue reading →

The BRCA Dilemma

15th May 2013 Yesterday’s revelation that Angelina Jolie has decided to speak publicly about having the BRCA1 mutation and her Continue reading →

World Ovarian Cancer Day

10th May 2013 This week saw the first ever World Ovarian Cancer Day – 8th May. The international collaboration was Continue reading →

Post navigation

← Older posts
Create a free website or blog at WordPress.com.
Gilda Witte
Blog at WordPress.com.
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Follow Following
    • Gilda Witte
    • Already have a WordPress.com account? Log in now.
    • Gilda Witte
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...